BRIXADI (buprenorphine) extended-release injection for subcutaneous use contains a medicine called buprenorphine. Buprenorphine is an opioid that can cause serious and life-threatening breathing …

Mar 22, 2026 · Brixadi is an extended-release injection of buprenorphine given by a healthcare provider that may be used to treat moderate to severe opioid use disorder (OUD) (also known as opioid …

Today, the U.S. Food and Drug Administration approved Brixadi (buprenorphine) extended-release injection for subcutaneous use (under the skin) to treat moderate to severe opioid use disorder...

BRIXADI is the ONLY injectable buprenorphine that offers multiple monthly and weekly dosing options. Patients currently on transmucosal buprenorphine treatment can be switched directly to BRIXADI …

Dec 16, 2024 · Find patient medical information for Brixadi (buprenorphine) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

Find a BRIXADI Treatment Provider Looking for a healthcare provider (HCP) who prescribes BRIXADI? Enter your city, state, or zip and your preferred search radius to find providers in your area.

Buprenorphine is generally used as a medication for treating opioid use disorder. In the United States, buprenorphine hydrochloride (and a combination formula, buprenorphine hydrochloride/naloxone,) …

Oct 30, 2024 · Brixadi is an extended-release form of buprenorphine (an FDA-approved medication used to treat OUD that can be prescribed in physician offices) that continuously releases and …

Dec 9, 2024 · Brixadi is a prescription drug used to treat opioid use disorder. Learn about the common, mild, and serious side effects it can cause and how to manage them.

Jul 31, 2023 · Brixadi (buprenorphine) is a partial opioid agonist. It works by attaching to the same receptors in the brain as opioids, but less strongly. It helps ease cravings and lower the risk for …